Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Berk

Showing results (321-330 of 398) with videos related to

Pageof 40
Sort By:
International Journal of Molecular Sciences|March 4, 2020
A Survey of Antimicrobial Resistance Determinants in Category A Select Agents, Exempt Strains, and Near-Neighbor SpeciesChris R Taitt, Tomasz A Leski, Amy Chen, et al.
Neurology and Therapy|July 31, 2023
Impact of Vutrisiran on Quality of Life and Physical Function in Patients with Hereditary Transthyretin-Mediated Amyloidosis with PolyneuropathyLaura Obici, Senda Ajroud-Driss, Kon-Ping Lin, et al.
Muscle & Nerve|April 6, 2026
Eplontersen for Hereditary Transthyretin Amyloidosis With Polyneuropathy: An Exploratory Analysis of Treatment Effect in Male and Female PatientsMárcia Waddington Cruz, John L Berk, Yeşim Parman, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|October 26, 2022
An additive destabilising effect of compound T60I and V122I substitutions in ATTRv amyloidosisTatiana Prokaeva, Elena S Klimtchuk, Polina Feschenko, et al.
Acta Neuropsychiatrica|July 12, 2016
Time course of illness prior to a diagnosis of bipolar disorder or schizoaffective disorderS Dodd, J Kulkarni, F Biffin, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|January 10, 2006
Quantitative serum free light chain assay in the diagnostic evaluation of AL amyloidosisHarun Akar, David C Seldin, Barbarajean Magnani, et al.
JAMA Neurology|January 13, 2025
Five-Year Results With Patisiran for Hereditary Transthyretin Amyloidosis With Polyneuropathy: A Randomized Clinical Trial With Open-Label ExtensionDavid Adams, Jonas Wixner, Michael Polydefkis, et al.
Gut|August 1, 1992
Antiviral effect of prolonged intermittent lymphoblastoid alpha interferon treatment in chronic hepatitis BH L Janssen, L Berk, S W Schalm, et al.
Blood|November 24, 2012
High-dose melphalan and stem cell transplantation for patients with AL amyloidosis: trends in treatment-related mortality over the past 17 years at a single referral centerStephanie B Tsai, David C Seldin, Karen Quillen, et al.
Blood|May 25, 2004
Improvement in quality of life of patients with AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantationDavid C Seldin, Jennifer J Anderson, Vaishali Sanchorawala, et al.
Pageof 40

Showing results (321-330 of 398) with videos related to

Sort By:
Pageof 40
International Journal of Molecular Sciences|March 4, 2020
A Survey of Antimicrobial Resistance Determinants in Category A Select Agents, Exempt Strains, and Near-Neighbor SpeciesChris R Taitt, Tomasz A Leski, Amy Chen, et al.
Neurology and Therapy|July 31, 2023
Impact of Vutrisiran on Quality of Life and Physical Function in Patients with Hereditary Transthyretin-Mediated Amyloidosis with PolyneuropathyLaura Obici, Senda Ajroud-Driss, Kon-Ping Lin, et al.
Muscle & Nerve|April 6, 2026
Eplontersen for Hereditary Transthyretin Amyloidosis With Polyneuropathy: An Exploratory Analysis of Treatment Effect in Male and Female PatientsMárcia Waddington Cruz, John L Berk, Yeşim Parman, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|October 26, 2022
An additive destabilising effect of compound T60I and V122I substitutions in ATTRv amyloidosisTatiana Prokaeva, Elena S Klimtchuk, Polina Feschenko, et al.
Acta Neuropsychiatrica|July 12, 2016
Time course of illness prior to a diagnosis of bipolar disorder or schizoaffective disorderS Dodd, J Kulkarni, F Biffin, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|January 10, 2006
Quantitative serum free light chain assay in the diagnostic evaluation of AL amyloidosisHarun Akar, David C Seldin, Barbarajean Magnani, et al.
JAMA Neurology|January 13, 2025
Five-Year Results With Patisiran for Hereditary Transthyretin Amyloidosis With Polyneuropathy: A Randomized Clinical Trial With Open-Label ExtensionDavid Adams, Jonas Wixner, Michael Polydefkis, et al.
Gut|August 1, 1992
Antiviral effect of prolonged intermittent lymphoblastoid alpha interferon treatment in chronic hepatitis BH L Janssen, L Berk, S W Schalm, et al.
Blood|November 24, 2012
High-dose melphalan and stem cell transplantation for patients with AL amyloidosis: trends in treatment-related mortality over the past 17 years at a single referral centerStephanie B Tsai, David C Seldin, Karen Quillen, et al.
Blood|May 25, 2004
Improvement in quality of life of patients with AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantationDavid C Seldin, Jennifer J Anderson, Vaishali Sanchorawala, et al.
Pageof 40